By Wendy Van Sickle
Columbus, Ohio, April 29 – Citigroup Global Markets Holdings Inc. priced $1.76 million of market-linked securities due April 27, 2023 – autocallable with contingent coupon and contingent downside linked to the least performing of the SPDR S&P Biotech ETF, according to a 424B2 filing with the Securities and Exchange Commission.
The notes are guaranteed by Citigroup Inc.
The notes will pay a contingent quarterly coupon at an annual rate of 10.85% if the ETF closes at or above its 75% coupon threshold on the observation date for that quarter.
The notes will be called at par if the ETF closes at or above its initial level on any quarterly observation date after six months.
The payout at maturity will be par unless the ETF finishes below its 75% downside threshold, in which case the payout will be par plus the return of ETF with full exposure to any losses.
Citigroup Global Markets Inc. and Wells Fargo Securities, LLC are the agents.
Issuer: | Citigroup Global Markets Holdings Inc.
|
Guarantor: | Citigroup Inc.
|
Issue: | Market linked securities – autocallable with contingent coupon and contingent downside
|
Underlying ETF: | SPDR S&P Biotech ETF
|
Amount: | $1,763,000
|
Maturity: | April 27, 2023
|
Coupon: | 10.85% annualized, payable quarterly if the ETF closes at or above 75% coupon threshold on observation date for that quarter
|
Price: | Par
|
Payout at maturity: | Par unless ETF falls by more than 25%, in which case 1% loss per 1% decline of worst performing index
|
Call: | At par if ETF closes at or above its initial level on any interest payment date beginning in October
|
Initial level: | $97.01
|
Coupon threshold/downside threshold: | $72.7575, 75% of initial level
|
Pricing date: | April 24
|
Settlement date: | April 29
|
Agents: | Citigroup Global Markets Inc. and Wells Fargo Securities, LLC
|
Fees: | 1.85%
|
Cusip: | 17328VX88
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.